Physician profile
Mark Warner
NPI 1679531487
$3,210.33
in general payments reported to CMS, 2019-2025
32 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $486 · 2021: $251 · 2022: $538 · 2023: $423 · 2024: $480 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $512.79 | 2020-2025 | Indigo System, Penumbra System |
| Pfizer INC. | $267.12 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $236.99 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.09 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $197.26 | 2019-2022 | |
| Boston Scientific Corporation | $163.34 | 2023-2025 | Watchman Flx, Watchman Access System |
| Esperion Therapeutics, INC. | $139.64 | 2020-2022 | |
| Amgen INC. | $139.17 | 2019-2023 | Repatha |
| Smith+Nephew, INC. | $135.78 | 2023 | Grafix |
| Imperative Care, INC | $128.86 | 2024 | Symphony Catheter |
| E.R. Squibb & Sons, L.L.C. | $123.93 | 2019-2023 | Eliquis, Camzyos |
| Philips North America LLC | $116.27 | 2022-2024 | (Ck4) Mcot |
| Astellas Pharma US INC | $112.42 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $102.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $88.22 | 2019-2023 | Xarelto |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $74.97 | 2020-2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $65.95 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Lundbeck LLC | $63.65 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.46 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $42.95 | 2022-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals Lp | $42.02 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $27.59 | 2024 | Optimizer |
| Alnylam Pharmaceuticals INC. | $25.53 | 2020-2022 | |
| Cardiva Medical, INC. | $21.67 | 2023 | Cardiva Vascade 6/7f Vcs |
| Akcea Therapeutics, INC. | $21.64 | 2019 | |
| Exact Sciences Corporation | $21.21 | 2023 | Cologuard Collection Kit |
| Atricure, INC. | $20.26 | 2021 | |
| Shield Therapeutics INC | $18.34 | 2023 | Accrufer |
| Heartflow, INC. | $17.93 | 2024 | |
| Merck Sharp & Dohme LLC | $14.49 | 2021 | |
| Medtronic Vascular, INC. | $13.38 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.83 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.